Download PDF
1 / Pages

Other users also viewed these articles

Update of the guidelines for the pharmacological treatment of rheumatoid arthritis by the Mexican College of Rheumatology 2023 Carlos Abud-Mendoza; Francisco Javier Aceves-Ávila; César Alejandro Arce-Salinas; José Álvarez Nemegyei; Leonor Barile-Fabris; Sergio Durán-Barragán; Diana Elsa Flores-Alvarado; Eufrates Hernández-Núñez; Fedra Irazoque-Palazuelos; José Francisco Moctezuma-Ríos; Virginia Pascual-Ramos; Margarita Portela-Hernández; Luis Humberto Silveira; Lilia Andrade-Ortega; Ana Barrera-Vargas; Sandra Carrillo-Vázquez; Zully Castro-Colin; Enrique Cuevas-Orta; Luis Felipe Flores-Suárez; Guillermo Arturo Guaracha-Basáñez; María Fernanda Hernández-Cabrera; Iván de Jesús Hernández-Galarza; David Alejandro Herrera-vanOostdam; Adriana Concepción Lobato-Belmonte; Laura Aline Martínez-Martínez; Marco Ulises Martínez-Martínez; Gabriel Medrano-Ramírez; Francisco Javier Merayo-Chalico; Graciela Meza-López y Olguín; Francisco Olan; Genaro Peña-Santos; César Ramos-Remus; Greta Reyes-Cordero; Vijaya Rivera-Terán; Jorge Rojas-Serrano; Griselda Serna-Peña; Sandra Sicsik-Ayala; César Armando Sifuentes-Cantú; David Vega-Morales; Pablo Villaseñor-Ovies; Daniel Xibillé-Friedmann; César Pacheco-Tena;
Reumatol Clin. 2024;20:263-80
Relevance of non-criteria antiphospholipid antibodies titers among patients with antiphospholipid syndrome and patients with systemic lupus erythematosus Tomás Urrego-Callejas; Alejandro Hernández; Sebastián Ruiz Giraldo; Beatriz Frade-Sosa; Adriana L. Vanegas-García; Carlos H. Muñoz; Carolina Rua; Julieta Duque Botero; Luis A. González; Gloria Vásquez; José A. Gómez-Puerta;
Reumatol Clin. 2023;19:197-203
Could Frida Kahlo have had antiphospholipid syndrome? Jorge Morales Torres; Francisco Javier Aceves; Mary Carmen Amigo Castañeda; Claudia Berenice Hernández Cuevas;
Reumatol Clin. 2022;18:65-8